(Q36617691)

English

Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

scientific article published on May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

0 references

author name string

Cao Z

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Joseph WR

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Browne WL

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mountjoy KG

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Palmer BD

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Baguley BC

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ching LM

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

80

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5-6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

716-723

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690415

0 references

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide is an inhibitor of angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Treatment of refractory rheumatoid arthritis--the thalidomide experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide does not perturb CD2, CD4, CD5, CD8, HLA-DR, or HLA-A, B, C molecules in vitro on the membranes of cells with immune potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

30 September 2017

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

28 June 2018

Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

28 June 2018

Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

28 June 2018

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

28 June 2018

Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

28 June 2018

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

20 September 2018

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362281

20 September 2018

Further Observation with Thalidomide in Lepra Reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide for graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PREPARATION OF ONE OF THE OPTICAL ANTIPODES OF 2-PHTHALIMIDOGLUTARIMIDE

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide as replacement for steroids in immunosuppression after lung transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and Teratogenicity of Optical Isomers of Thalidomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10360649

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6690415

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36617691&oldid=1517382695"